WANBURY LIMITED Share Price

₹ 190.52

+₹1.31 (0.69%)
1D
Last updated 02 Nov, 2026, 15:58 IST
NSE: WANBURY
|
Pharmaceuticals

WANBURY LIMITED Share Price Today

As of 2 Nov 2026, WANBURY LIMITED share price is ₹190.52. The stock opened at ₹190.88, compared to its previous close of ₹189.21. During today's trading session, WANBURY LIMITED share price moved in the range of ₹188.20 to ₹194.80, with an average price of ₹191.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹161.50 and a high of ₹358.85. On the performance front, WANBURY LIMITED share price has declined by 25.59% over the last six months and is down 26.51% on a year-on-year basis.

Share price over the last 1 day fell from 193.50 to 188.34, ranging between 188.34 and 194.01.
₹188.20
0.69% up today
₹194.80
1D LOW
1D HIGH

WANBURY LIMITED Stock Insights

Latest Earning
Op Profit TrendDown by 28.56% QoQ
Latest Earning
Net Profit TrendDown by 33.42% QoQ
Latest Earning
Revenue TrendUp by 4.21% YoY
Stock Performance
UnderperformingUnderperforming Nifty by 17.81 % in last 1 yr
Shareholding Pattern
PromoterPromoter decreased stake by 0.08%
Shareholding Pattern
DIIDII decreased stake by 97.46%
Shareholding Pattern
FIIFII decreased stake by 20.04%
WANBURY LIMITED stock performance
Open₹190.88
High₹194.80
Low₹188.20
Prev. close₹189.21
WANBURY LIMITED trading activity
Volume1,04,828
Average traded price₹190.84
Last traded time03:58:50 02 Nov
Last traded quantity200
Circuit
L
H
₹151.37
₹227.05
52-week
L
H
₹161.50
₹358.85
Mkt Cap Cr
663.50
P/E
15.44
P/B
8.56
ROA
10.39%
ROE
51.51%
ROCE
27.98%
Quick Ratio
0.89
EV/EBITDA
8.93

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Wanbury has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Wanbury appears overvalued compared to its peers
Earnings: 2 out of 5, Poor
Earnings
Poor
Wanbury earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

WANBURY LIMITED Company Background

ISIN
INE107F01022
Sector Market Cap
₹ 663.50 Cr

Wanbury Limited is an India-based pharmaceutical company with a presence in the active pharmaceutical ingredients (APIs) global market and domestic branded formulations. The Company is engaged in the business of pharmaceutical and related activities, including research. Its API products include Metformin, Metformin Dc, Tramadol, Sertraline, Diphenhydramine HCL, Diphenhydramine Citrate, Mefenamic Acid, Paroxetine Hemihydrate, Promethazine, Glucosamine, Clopidogrel, Levetiracetam and Carvedilol Phosphate Monohydrate. In formulations, the Company has a presence across various therapeutic categories, such as cough and cold solutions, gynecology, orthopedics, nutraceuticals, gastrointestinal, anti-inflammatory and analgesics. The Company is also focused on the development of products like ketamine, rivaroxaban, montelukast, sitagliptin and a few others to reduce dependency on metformin and sertraline. The Company has facilities in Tanuku, Andra Pradesh, and Patalganga, Maharashtra.

WANBURY LIMITED Financial Highlights

  • Revenue: WANBURY LIMITED reported revenue of ₹603.00 crore in FY25 vs ₹578.64 crore in FY24. It showed an increase of 4.21% on a yearly basis.
  • Operating Profit: WANBURY LIMITED reported an operating profit of ₹29.55 crore in FY25 vs ₹56.34 crore in FY24. It showed a decrease of 47.55% on a year-on-year basis.
  • Net Profit: WANBURY LIMITED reported a net profit of ₹30.53 crore in FY25 vs ₹55.96 crore in FY24. It showed a decrease of 45.44% on a yearly basis.

WANBURY LIMITED Quarterly Result Highlights

  • WANBURY LIMITED reported revenue of ₹163.53 crore in Jun 2025, compared with ₹173.84 crore in Mar 2025, representing a decrease of 5.93% on a quarter-on-quarter (QoQ) basis.
  • WANBURY LIMITED reported an operating profit of ₹13.61 crore in Jun 2025, compared with ₹19.05 crore in Mar 2025, representing a decrease of 28.56% on a quarter-on-quarter (QoQ) basis.
  • WANBURY LIMITED reported a profit of ₹13.49 crore in Jun 2025, compared with ₹20.26 crore in Mar 2025, reflecting a decrease of 33.42% on a QoQ basis.
  • The earnings per share (EPS) of WANBURY LIMITED stood at ₹9.32 during Jun 2025.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
42.98%
FII
0.71%
Other DII
0.00%
Retail and other
56.30%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.72%
Mar 20260.59%
Jun 20260.89%
Sep 20260.71%

WANBURY LIMITED Investment Returns

1 day
+4.00%
1 week
+6.02%
1 month
-5.16%
1 year
-26.51%
3 years
+109.07%
5 years
+191.77%

WANBURY LIMITED Share Price History

WANBURY LIMITED share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹180.00 / ₹189.21
+4.00%
29 Oct 26
₹174.92 / ₹181.93
+4.46%
28 Oct 26
₹177.00 / ₹174.16
-1.06%
27 Oct 26
₹169.74 / ₹176.02
+5.77%
Show more

WANBURY LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹599.51₹575.65₹499.65₹511.19
Other Income₹3.49₹2.99₹0.91₹1.51
Total Revenue₹603.01₹578.64₹500.56₹512.69
Total Expenses₹573.46₹547.86₹510.25₹507.93
Profit Before Tax₹29.55₹56.34-₹10.29₹81.13
Tax-₹0.98₹0.38₹0.11-₹0.35
Profit After Tax₹30.53₹55.96-₹10.40₹81.47
EPS - Basic₹9.32₹17.10-₹3.18₹25.29
EPS - Diluted₹8.98₹16.89-₹3.18₹25.21

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹29.55₹56.34-₹10.29₹81.13
Income before WC changes₹77.53₹72.39₹26.72₹37.45
Change in Assets-₹30.39-₹36.09₹27.33-₹60.30
Change in Liabilities-₹20.66-₹32.14-₹34.08₹63.54
Change in WC-₹51.06-₹68.23-₹6.75₹3.24
Cash flow from Operations₹26.10₹3.98₹19.80₹40.52
Cash flow from Investing-₹51.17-₹16.63-₹8.84₹0.59
Cash flow from Financing₹25.73₹14.55-₹31.99-₹28.58
Total Cash Flow₹0.66₹1.91-₹21.03₹12.52
Cash (Start of the year)₹3.40₹1.49₹22.53₹10.00
Cash (End of the year)₹4.06₹3.40₹1.49₹22.53

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹220.47₹184.21₹181.71₹181.31
Current Assets₹193.44₹159.29₹121.81₹171.24
Total Assets₹413.92₹343.49₹303.52₹352.55
Current Liabilities₹174.61₹214.11₹320.03₹359.77
Net Current Asset₹18.83-₹54.82-₹198.22-₹188.53
Non-Current Liabilities₹180.03₹101.45₹16.31₹16.20
Equity Capital₹59.27₹27.94-₹32.82-₹23.42
Total Equity & Liabilities₹413.92₹343.49₹303.52₹352.55

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹650.27₹599.51₹577.74₹499.65
Other Income₹0.94₹3.49₹0.90₹0.91
Total Revenue₹651.21₹603.01₹578.64₹500.56
Total Expenses₹587.80₹573.46₹547.86₹510.25
Profit Before Tax₹59.80₹29.55₹30.78-₹10.29
Tax-₹6.33-₹0.98₹0.38₹0.11
Profit After Tax₹66.13₹30.53₹30.40-₹10.40
EPS - Basic₹19.49₹9.32₹9.29-₹3.18
EPS - Diluted₹19.42₹8.98₹9.18-₹3.18

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹63.41₹29.55₹30.78-₹10.29
Income before WC changes₹108.91₹77.63₹72.39₹26.72
Change in Assets-₹46.27-₹30.39-₹38.45₹27.36
Change in Liabilities-₹30.16-₹20.66-₹29.06-₹34.11
Change in WC-₹76.43-₹51.06-₹67.51-₹6.75
Cash flow from Operations₹31.53₹26.20₹4.70₹19.80
Cash flow from Investing-₹56.40-₹51.17-₹16.63-₹8.84
Cash flow from Financing₹22.42₹25.63₹13.87-₹31.99
Total Cash Flow-₹2.45₹0.66₹1.94-₹21.03
Cash (Start of the year)₹4.06₹3.40₹1.46₹22.49
Cash (End of the year)₹1.61₹4.06₹3.40₹1.46

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹279.11₹220.60₹184.51₹181.71
Current Assets₹238.56₹193.32₹158.61₹120.19
Total Assets₹517.67₹413.92₹343.12₹301.90
Current Liabilities₹201.04₹174.61₹210.70₹292.84
Net Current Asset₹37.52₹18.70-₹52.09-₹172.66
Non-Current Liabilities₹172.18₹180.03₹104.48₹16.31
Equity Capital₹144.45₹59.27₹27.94-₹7.26
Total Equity & Liabilities₹517.67₹413.92₹343.12₹301.90
* All values are in INR Crore
WANBURY LIMITED market depth
Bid quantityBid priceAsk priceAsk quantity
00190.52458
0000
0000
0000
0000
Total bid quantity0
Total ask quantity458
WANBURY LIMITED technical summary
Bearish indicators3
Neutral indicators5
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
44.71
Neutral
ATR (14)
10.94
Neutral
STOCH(9,6)
74.14
Neutral
STOCH RSI (14)
100
Bearish
ADX(9)
50.32
Bearish
UO(9)
46.39
Neutral
ROC(12)
-2.16
Bearish
WillR(14)
-29.59
Neutral
Period
Simple value
Exponential vaue
5D
177.55
181.98
10D
181.81
183.07
20D
187.83
190.62
50D
219.89
214.64
100D
253.49
235.48
Volume trend — traded volume by day
2 Nov1L
30 Oct3L
29 Oct1L
28 Oct0L
27 Oct1L
26 Oct3L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

WANBURY LIMITED
Pharmaceuticals
Add Stock
Add Another

WANBURY LIMITED Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

WANBURY LIMITED Share Price FAQs

Please be aware that WANBURY LIMITED stock prices are subject to continuous fluctuations due to various factors.